HPR125 Analysis of IPT Developed for the New Medicines and Indications Authorized by the European Commission During the 2021-2023 Period
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.1551
https://www.valueinhealthjournal.com/article/S1098-3015(24)04414-0/fulltext
Title :
HPR125 Analysis of IPT Developed for the New Medicines and Indications Authorized by the European Commission During the 2021-2023 Period
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)04414-0&doi=10.1016/j.jval.2024.10.1551
First page :
Section Title :
Open access? :
No
Section Order :
11015